SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (“Ecstasy”)
11 references·10 citing·39 second hop
Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (“Ecstasy”) (2001)Increased anxiety and impaired memory in …Cognitive performance and serotonergic function in users of ecstasy (2001)Cognitive performance and ser…Working memory deficits in current and previous users of MDMA (‘ecstasy’) (2000)Working memory deficits in cu…Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users (2000)Psychobiological problems in …Memory disturbances in ”Ecstasy" users are correlated with an altered brain serotonin neurotransmission (2000)Memory disturbances in ”Ecsta…Long-lasting effects of (±)3,4-methylene-dioxymethamphetamine (Ecstasy) on serotonin system function in humans (2000)Long-lasting effects of (±)3,…Ecstasy (MDMA): a review of its possible persistent psychological effects (2000)Ecstasy (MDMA): a review of i…Reducedin vivobinding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users (1999)Reducedin vivobinding to the …Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study (1999)Cognitive performance in (±) …Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. (1992)Lasting effects of (+-)-3,4-m…Ethologically-based animal models of anxiety disorders (1990)Ethologically-based animal mo…3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987)3,4-Methylenedioxymethampheta…Neurotoxicity of drugs of abuse - the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines (2009)Neurotoxicity of drugs of abu…Ecstasy: Are animal data consistent between species and can they translate to humans? (2006)Ecstasy: Are animal data cons…3,4-Methylenedioxymethamphetamine in Adult Rats Produces Deficits in Path Integration and Spatial Reference Memory (2005)3,4-Methylenedioxymethampheta…Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period (2004)Memory deficit and reduced an…MDMA (“ecstasy”), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat (2004)MDMA (“ecstasy”), methampheta…Ecstasy: pharmacology and neurotoxicity (2004)Ecstasy: pharmacology and neu…Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes (2003)Increased anxiety and "depres…Increased Anxiety 3 Months after Brief Exposure to MDMA (‘Ecstasy’) in Rats: Association with Altered 5-HT Transporter and Receptor Density (2003)Increased Anxiety 3 Months af…Chronic Fluoxetine Treatment Partly Attenuates the Long-Term Anxiety and Depressive Symptoms Induced by MDMA (‘Ecstasy’) in Rats (2003)Chronic Fluoxetine Treatment …Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion (2002)Increased anxiety in rats aft…Conflict, arousal, and curiosity. (1960)Cognitive, social, and physiological determinants of emotional state. (1962)Helplessness: On Depression, Development, and Death (1975)Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior (2001)An estrogen-dependent four-gene micronet regulating social recognition: A study with oxytocin and estrogen receptor-α and -β knockout mice (2003)Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus (2008)A revised version of the psychoticism scale (1985)Computerized assessment in neuropsychiatry using CANTAB: discussion paper. (1992)Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings (1998)Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? (2001)Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy (2005)Exploring the Central Executive (1996)Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug (2001)Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users (2002)The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview (2006)Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug (1992)Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance (1998)Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies (2001)Memory impairment in abstinent MDMA ("Ecstasy") users (1998)Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") (2001)Altered states: the clinical effects of Ecstasy (2003)Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users (2003)Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. (1987)Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans (1994)The relative contributions of ecstasy and cannabis to cognitive impairment (2000)Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview (2009)A Standardized Memory Scale for Clinical Use (1945)An inventory for assessing different kinds of hostility. (1957)A Systematic Method for Clinical Description and Classification of Personality Variants (1987)Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research (2001)Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity (2002)3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings (2006)Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits (1998)Cognitive performance amongst recreational users of "ecstasy" (2000)Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons (2001)MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons (1988)Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. (1988)Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems (2001)Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms (2003)
this work references cited by second hop

References

  • 1990Ethologically-based animal models of anxiety disorders849 cited
  • 19873,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.458 cited
  • 2000Ecstasy (MDMA): a review of its possible persistent psychological effects380 cited
  • 1999Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study300 cited
  • 1999Reducedin vivobinding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users280 cited
  • 2000Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users279 cited
  • 1992Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.268 cited
  • 2001Cognitive performance and serotonergic function in users of ecstasy233 cited
  • 2000Memory disturbances in ”Ecstasy" users are correlated with an altered brain serotonin neurotransmission210 cited
  • 2000Working memory deficits in current and previous users of MDMA (‘ecstasy’)185 cited
  • 2000Long-lasting effects of (±)3,4-methylene-dioxymethamphetamine (Ecstasy) on serotonin system function in humans138 cited

Cited by

  • 2006Ecstasy: Are animal data consistent between species and can they translate to humans?126 cited
  • 2004Ecstasy: pharmacology and neurotoxicity

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

125 cited
  • 2003Increased Anxiety 3 Months after Brief Exposure to MDMA (‘Ecstasy’) in Rats: Association with Altered 5-HT Transporter and Receptor Density122 cited
  • 2009Neurotoxicity of drugs of abuse - the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines113 cited
  • 2002Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion107 cited
  • 2004Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period97 cited
  • 2003Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes92 cited
  • 2003Chronic Fluoxetine Treatment Partly Attenuates the Long-Term Anxiety and Depressive Symptoms Induced by MDMA (‘Ecstasy’) in Rats85 cited
  • 2004MDMA (“ecstasy”), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat81 cited
  • 20053,4-Methylenedioxymethamphetamine in Adult Rats Produces Deficits in Path Integration and Spatial Reference Memory79 cited